Jushi Holdings (JUSHF) Interest & Investment Income (2021 - 2026)
Jushi Holdings (JUSHF) reported Interest & Investment Income of -$10.4 million for Q1 2026, down 3.88% year-over-year from -$10.8 million in Q1 2025, and little changed quarter-over-quarter from -$10.4 million in Q4 2025.
Jushi Holdings (JUSHF) Interest & Investment Income (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Interest & Investment Income data on file, last reported at -$10.4 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at -$10.4 million, down 3.88% year-over-year; the trailing twelve-month figure through Mar 2026 was -$41.2 million (down 8.85% YoY), and the FY2025 annual result was -$40.8 million, down 9.14% from the prior year.
- Interest & Investment Income steadied at -$10.4 million in Q1 2026 per JUSHF's latest filing, from -$10.4 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at -$8.5 million in Q1 2023 and troughed at -$13.1 million in Q3 2022.
- A 5-year average of -$10.1 million and a median of -$10.0 million in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income slumped 76.18% in 2022, then grew 28.72% in 2023.
- A 5-year view of Interest & Investment Income shows it stood at -$11.4 million in 2022, then advanced by 18.45% to -$9.3 million in 2023, then decreased by 1.26% to -$9.4 million in 2024, then declined by 9.87% to -$10.4 million in 2025, then decreased by 0.28% to -$10.4 million in 2026.
- Business Quant data shows JUSHF's Interest & Investment Income at -$10.4 million in Q1 2026, -$10.4 million in Q4 2025, and -$10.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Jushi Holdings | - | - | 29.88 Mn | -10.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.39 Mn |
| Dec 31, 2025 | -10.36 Mn |
| Sep 30, 2025 | -10.27 Mn |
| Jun 30, 2025 | -10.22 Mn |
| Mar 31, 2025 | -10.00 Mn |
| Dec 31, 2024 | -9.43 Mn |
| Sep 30, 2024 | -9.38 Mn |
| Jun 30, 2024 | -9.07 Mn |
| Mar 31, 2024 | -9.54 Mn |
| Dec 31, 2023 | -9.31 Mn |
| Sep 30, 2023 | -9.35 Mn |
| Jun 30, 2023 | -9.79 Mn |
| Mar 31, 2023 | -8.52 Mn |
| Dec 31, 2022 | -11.42 Mn |
| Sep 30, 2022 | -13.11 Mn |
| Jun 30, 2022 | -10.95 Mn |
| Mar 31, 2022 | -10.12 Mn |
| Dec 31, 2021 | -9.47 Mn |
| Sep 30, 2021 | -7.44 Mn |
| Jun 30, 2021 | -6.87 Mn |